-
ARRAY 797-301
A phase 3, multinational, randomized, placebo-controlled study of ARRY-371797 in patients with symptomatic dilated cardiomyopathy due to a lamin A/C gene mutation.
Type: Drug trial
Principal Investigator: Saurabh Kapoor, MD
Trial is open for enrollment
For inquiries, call
(973) 926-8451
-
EARLY TAVR
Evaluation of Transcatheter Aortic Valve Replacement (TAVR) compared to surveillance for patients with asymptomatic severe aortic stenosis.
Type: Device trial
Principal Investigator: Sergio Waxman, MD (NBIMC)
Trial is open for enrollment
For inquiries, call (973) 926-6938 (NBIMC)
For inquiries, call
(973) 926-6938
-
EVP-DEV-LTX-301
The objective of this study is to evaluate the safety and effectiveness of the CLES in enabling evaluation of potential donor lungs not otherwise used for transplant into subjects with end stage, survival-limiting lung disease in need of lung transplantation.
Type: Device trial
Principal Investigator: Jesus Gomez-Abraham, MD
Trial is open for enrollment
For inquiries, call (973) 926-8451
For inquiries, call
(973) 926-8451
-
GUIDE-HF
A study designed to demonstrate the effectiveness of the CardioMEMS Heart Failure System in an expanded patient population, including heart failure patients outside of the present indication, but at risk for future heart failure (HF) events or mortality.
Type: Device trial
Principal Investigator: Donald Rubenstein, MD
Trial is open for enrollment
For inquiries, call
(973) 926-8451
-
HEP-COVID
Systemic anticoagulation with full dose low molecular weight heparin (LMWH) Vs. Prophylactic or Intermediate dose LMWH in high-risk COVID-19 patients.
Type: Drug
Principal Investigator: Marc Cohen, MD
Trial is open for enrollment
For inquiries, call
(973) 926-8451
-
NACMI
This registry is a research study designed to collect data on COVID-19 positive patients or persons under investigation (suspected to have COVID-19 infection) with ST-Elevation Myocardial Infarction (STEMI).
Principal Investigator: Bruce Haik, MD
Type: Chart Review/Registry
Trial is open for enrollment
For inquiries, call
(862) 280-2701
-
PARTNER 3
A study designed to establish the safety and effectiveness of the SAPIEN 3 Transcatheter Heart Valve (THV) in low-risk patients requiring aortic valve replacement who have severe, calcific, symptomatic aortic stenosis.
Type: Device trial
Principal Investigator: Sergio Waxman, MD
Trial is open for enrollment
For inquiries, call
(973) 926-6938
-
PFO PAS
The purpose of this study is to confirm the safety and effectiveness of the AMPLATZER PFO Occluder in the post approval setting.
Type: Device trial
Principal Investigator: Marc Cohen, MD
Trial is open for enrollment
For inquiries, call
(973) 926-8451
-
PORTICO
A study designed to evaluate the safety and effectiveness of the SJM Portico Transcatheter Heart Valve (THV) and Delivery Systems via transfemoral and alternative delivery methods.
Type: Device trial
Trial is open for enrollment
View All Details
For inquiries, call
(973) 926-6938
-
SUMMIT-Tendyne
Evaluation of the safety and effectiveness of using the Tendyne Mitral Valve System for the treatment of symptomatic mitral regurgitation
Type: Device trial
Principal Investigators: Arash Salemi, MD (NBIMC and SBMC) or Mark Russo, MD (RWJMS/RWJUH)
Trial open for enrollment (MAC registry only)
For inquiries, call (973) 926-6938 (NBIMC) or (732) 235-9215 (RWJMS/RWJUH)